Price transparency of cancer medicines: a crucial step towards informed pricing negotiations in the European region
Our study is one of few providing discounts and actual prices for 15 cancer medicines, revealing large price variations between and within countries. Additionally, reference prices often fail to provide an accurate indication of the actual price and hospitals have often misguided perceptions on their negotiation performance. Transparent, standardized reporting of prices and coordinated collaborations are essential to strengthen the bargaining power of hospitals and foster informed price negotiations.
Authors
- M Hug
- Nora Franzen (ORCID: https://orcid.org/0000-0002-4539-1709)
- Anne M. P. Eldering-Heldens
- Julie M. Vancoppenolle (ORCID: https://orcid.org/0000-0003-2193-8391)
- Albane Degrassat-Théas (ORCID: https://orcid.org/0000-0002-2866-332X)
- Ulrich Warnke (ORCID: https://orcid.org/0009-0000-9991-2015)
- Péter Vajda (ORCID: https://orcid.org/0000-0001-8788-482X)
- Aniek Dane (ORCID: https://orcid.org/0000-0001-6371-9248)
- Valesca P. Retèl (ORCID: https://orcid.org/0000-0002-5624-3234)
- V Ladisa
- Cristina Andrianò
- Holger Knoth
- Wim H. van Harten
- Zora Ćetković
- Morten Baltzer Houlind
Institutions
- Semmelweis University (HU)
- University of Copenhagen (DK)
- Inserm (FR)
- University of Freiburg (DE)
- Université Paris Cité (FR)
- Amager Hospital (DK)
- University Medical Center Freiburg (DE)
- Erasmus MC (NL)
- Copenhagen University Hospital (DK)
- Sorbonne Paris Cité (FR)
- Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IT)
- The Capital Region Pharmacy (DK)
- Department of Health (TW)
- Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NL)
- Organisation of European Cancer Institutes (BE)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- Klinikum Ernst von Bergmann (DE)
- University Hospital Carl Gustav Carus (DE)
- University of Twente (NL)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2026-03-09
- DOI
- https://doi.org/10.3389/fphar.2026.1736741
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00